Patents/Assignees

Rigel Pharmaceuticals, Inc.

25 patents in portfolio

US11667643utility2023
RIP1K Inhibitors
0 cites
US11584758utility2023
RIP1K Inhibitors
0 cites
US11578078utility2023
Heterocyclic RIP1 Inhibitory Compounds
0 cites
US11564930utility2023
RIP1 Inhibitory Compounds and Methods for Making and Using the Same
0 cites
US8343954utility2013
Compositions and Methods for Inhibition of the JAK Pathway
0 cites

← PreviousPage 2 of 2